You searched for "care"
A rare case of oculomotor nerve palsy from presumed cavernous angioma
Cavernous angiomas of the cranial nerves are extremely rare, and those of the oculomotor (third) nerve are rarer still. The authors present a single case study of presumed cavernous angioma involving the subarachnoid portion of the left third nerve, which...
A case report of papilloedema caused by unilateral jugular vein thrombosis
In rare cases, unilateral jugular vein thrombosis can lead to increased intracranial pressure and papilloedema, resulting in headaches and visual loss. The authors describe the case of a 45-year-old patient with squamous cell carcinoma of the larynx who developed right...
A case of progressive supranuclear palsy-like syndrome following aortic aneurysm repair
This original article illustrates the case of an 18-year-old woman who developed progressive supranuclear palsy-like syndrome following an uneventful aortic aneurysm repair. The patient was unaffected for the first 48 hours after surgery and then developed dysarthria, dysphagia (requiring a...
Risk of pulled-in-two syndrome
Congenital fibrosis of the extraocular muscles (CFEOM) is along the risk factors for pulled-in-two syndrome (PITS). The aim of this study was to report six cases and discuss prevention and clinical management strategies. The author’s six cases represented an incidence...
An unusual case report of bilateral abducens paralysis
In this case report a nine-year-old girl develops bilateral abducens nerve paralysis, caused by vertebrobasilar dolichoectasia. Vertebrobasilar dolichoectasia is characterised by dilation, tortuosity and marked elongation of the vertebral and basilar arteries. Clinical findings result from the compression and displacement...
Licence to save: a UK survey of anti-VEGF use for the eye
This comment article highlights the controversy that exists in the choice for anti-VEGF drugs used for treatment of macular oedema and wet age-related macular degeneration (AMD). Two existing licensed drugs for macular oedema are ranibizumab (Lucentis) and aflibercept (Eylea). A...RNIB and Abertay University hold event to reboot gaming to make it more accessible for those with sight loss
Sight loss charity Royal National Institute of Blind People (RNIB) and Abertay University in Dundee will host a pioneering Accessible Gaming Symposium this week.
